|
SLC35A1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.492100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.404300E-03 |
| Normal-vs-Stage2 |
1.746020E-01 |
| Normal-vs-Stage3 |
5.184600E-01 |
| Normal-vs-Stage4 |
8.975600E-01 |
| Stage1-vs-Stage2 |
8.893600E-01 |
| Stage1-vs-Stage3 |
2.495600E-02 |
| Stage1-vs-Stage4 |
1.236210E-02 |
| Stage2-vs-Stage3 |
3.239200E-01 |
| Stage2-vs-Stage4 |
2.064000E-01 |
| Stage3-vs-Stage4 |
6.056400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.689600E-02 |
| Normal-vs-AfricanAmerican |
5.112200E-01 |
| Normal-vs-Asian |
4.666800E-01 |
| Caucasian-vs-AfricanAmerican |
3.665200E-01 |
| Caucasian-vs-Asian |
9.587600E-01 |
| AfricanAmerican-vs-Asian |
7.375200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.889900E-02 |
| Normal-vs-Female |
1.930400E-02 |
| Male-vs-Female |
3.242800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.796200E-01 |
| Normal-vs-Age(41-60Yrs) |
6.205800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.115600E-02 |
| Normal-vs-Age(81-100Yrs) |
3.470000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.833200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.789180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.789000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.403800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.272200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.874800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.54269999999813E-05 |
| Normal-vs-Grade 2 |
1.350840E-04 |
| Normal-vs-Grade 3 |
5.907800E-01 |
| Normal-vs-Grade 4 |
1.530550E-01 |
| Grade 1-vs-Grade 2 |
1.497900E-02 |
| Grade 1-vs-Grade 3 |
2.32349999998993E-05 |
| Grade 1-vs-Grade 4 |
2.72720000027427E-07 |
| Grade 2-vs-Grade 3 |
3.74570000000185E-05 |
| Grade 2-vs-Grade 4 |
1.77849999949409E-07 |
| Grade 3-vs-Grade 4 |
2.560300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.72029999981838E-07 |
| Normal-vs-ccB subtype |
4.438400E-01 |
| ccA subtype-vs-ccB subtype |
7.48420214691237E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.498200E-02 |
| Normal-vs-N1 |
2.654200E-01 |
| N0-vs-N1 |
8.358100E-02 |
|
|
